|
SESTD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.78703751585863E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.74009994880731E-09 |
| Normal-vs-Stage2 |
1.182130E-02 |
| Normal-vs-Stage3 |
5.604400E-02 |
| Normal-vs-Stage4 |
1.884830E-01 |
| Stage1-vs-Stage2 |
9.495000E-01 |
| Stage1-vs-Stage3 |
5.056600E-01 |
| Stage1-vs-Stage4 |
6.249800E-01 |
| Stage2-vs-Stage3 |
6.860600E-01 |
| Stage2-vs-Stage4 |
6.979600E-01 |
| Stage3-vs-Stage4 |
9.743600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.67049765318484E-11 |
| Normal-vs-AfricanAmerican |
7.58160000000618E-05 |
| Normal-vs-Asian |
2.228400E-01 |
| Caucasian-vs-AfricanAmerican |
1.660230E-01 |
| Caucasian-vs-Asian |
3.682900E-03 |
| AfricanAmerican-vs-Asian |
4.744300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.56199997170381E-09 |
| Normal-vs-Female |
1.42830000049443E-07 |
| Male-vs-Female |
1.519990E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.199700E-03 |
| Normal-vs-Extreme_Weight |
7.56240000000519E-05 |
| Normal-vs-Obese |
1.8031400000007E-05 |
| Normal-vs-Extreme_Obese |
1.258570E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.490600E-01 |
| Normal_Weight-vs-Obese |
4.145400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.550200E-01 |
| Extreme_Weight-vs-Obese |
2.753200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.361800E-01 |
| Obese-vs-Extreme_Obese |
3.390400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.669600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.58090002094968E-09 |
| Normal-vs-Age(61-80Yrs) |
4.86899999985191E-07 |
| Normal-vs-Age(81-100Yrs) |
1.707370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.417400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.273200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.795040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.499700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.870620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.708600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.8204109854596E-13 |
| Normal-VS-Type2 PRCC |
3.736100E-02 |
| Normal-VS-KIRP CIMP |
1.488380E-02 |
| Normal-VS-Unclassified PRCC |
8.782900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.580910E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.023600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.571000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.757600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.130200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.320300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.159600E-02 |
| Normal-vs-N1 |
6.331800E-02 |
| Normal-vs-N2 |
3.115000E-01 |
| N0-vs-N1 |
4.443000E-01 |
| N0-vs-N2 |
4.579800E-01 |
| N1-vs-N2 |
5.036200E-01 |
|
|
